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Background
COPD is a smoke-related disease, character-
ized by largely irreversible airflow obstruction. Pa-
tients suffer from variable grades of impaired qual-
ity of life and the disease is often complicated by
co-morbidities, making it one of the more complex
chronic diseases seen by general practitioners.
Because of the complexity of the disease, di-
agnostic problems are common: symptoms are not
always recognised by patients and health care
workers, and patients greatly underestimate the
severity of their disease [1]. Moreover, when diag-
nosed, patients frequently receive insufficient
treatment [2].
COPD forms a major cause of chronic morbid-
ity and mortality worldwide and, according to the
WHO, will be the third leading cause of death in
2030 [3]. Given the rise in incidence, COPD con-
stitutes an important financial and health burden in
coming decades.
The most effective non-pharmacological and
pharmacological treatment, besides smoking ces-
sation, is pulmonary rehabilitation (PR), which
has been widely recommended [4, 5]. PR refers to
an integrated, multidisciplinary treatment of
COPD, aiming at reducing dyspnoea and symp-
toms. Integrated into the treatment of the patient,
PR is designed to optimize functional status, in-
crease participation and reduce healthcare costs.
Ideally, PR programs are individually tailored and
designed to promote education and self-manage-
ment skills in combination with personal exercise
training [4]. Beneficial effects are well established
in severe to very severe patients [6], and signifi-
cant improvements in exercise capacity, dyspnoea
and health-related quality of life have been report-
ed [7-10].
Nevertheless, despite proven efficacy and wide
recommendation [4, 5, 11, 12], PR is still not avail-
able in the vast majority of cases.
Capacity problems
Even though the benefits of PR are widely es-
tablished, daily use is limited. There are several
reasons for this.
First, access is poor and services are frequent-
ly unavailable for patients who would benefit from
PR programs [13]. Overall, admission to a pro-
gram is only considered for a small proportion of
the COPD population, usually the most severely
affected patients.
A disequilibrium between demand and supply
of PR services is the result, and consequently,
health care workers are confronted with capacity
problems [13]. As a striking example, it was con-
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Chronic obstructive pulmonary disease (COPD) rep-
resents a major and progressive cause of morbidity and
mortality worldwide, resulting in an important financial
and health burden in coming decades. Pulmonary reha-
bilitation (PR) has been proven to be the most effective
treatment in all patients in whom respiratory symptoms
are associated with diminished functional capacity or re-
duced quality of life. Nevertheless, despite wide recom-
mendation and proven efficacy, the use of PR is limited in
daily practice. Reasons for these include low accessibility
and availability, high costs, and lack of motivation to con-
tinue a healthy life style after treatment. By contrast, it
has been demonstrated that primary care patients can be
reactivated by formulating personal targets and design-
ing individualized treatment plans in collaboration with
their general practitioner or practice nurse. Based on
these personal plans and targets, specific education must
be provided and development of self management skills
should be actively encouraged. Ideally, elements of pul-
monary rehabilitation are tailored into a comprehensive
primary care integrated disease management program.
In that way, the benefits of PR can be extended to a sub-
stantially larger part of the COPD population, to reach
even those with milder stages of disease. Favorable long-
term effects on exercise tolerance and quality of life in a
number of studies have been demonstrated in recent
years, but broad introduction in the primary care setting
still needs further justification in the form of a proper
cost effectiveness analysis.
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cluded in a UK survey that only 1% of the COPD
population had access to a PR program [14]. These
results are confirmed in a more recent Canadian
study, where it was found that only 1.2% of the
COPD population was able to follow a PR pro-
gram [15]. Availability of PR programs at hospital
settings differs considerably among countries. A
survey across North America, Europe and Japan in
1999 indicated that PR programs were available at
56% of hospitals in North America and 74% in Eu-
rope, but at only 20% of hospitals in Tokyo [16].
Second, due to its highly specialized setting,
PR programs are costly (but cost-effective) inter-
ventions: each rehabilitation program (maximum
of 20 patients) has been calculated to cost £
12.120, equalling approximately € 14.280 per pa-
tient [17]. As a result of these high costs, services
have often been available for those patients in
whom quality of life has already deteriorated to a
large extent only, and prognosis is dire.
Generally speaking, it is considered a “last-
ditch” effort for patients with only the most severe
forms of COPD [18]. This is in contrast with the
American Thoracic Society/European Respiratory
Society (ATS/ERS) Statement on Pulmonary Reha-
bilitation and recent GOLD Guidelines, that actual-
ly recommend PR for all patients in whom respira-
tory symptoms are associated with diminished func-
tional capacity or reduced quality of life [4, 19].
This recommendation is backed up by results of ear-
lier studies, where PR has been proven to be effec-
tive, regardless of disease severity [20, 21]. In fact,
especially improvements in milder stages of disease
could slow down disease progression considerably.
In addition, exercise training on its own, which
forms one of the major components of PR, has
shown improvements in fitness of mild to moder-
ate COPD patients [22].
A third problem with PR is the fact that it usu-
ally consists of a separate program running paral-
lel to standard care. Furthermore, it is only admin-
istered during a limited period of time. Patients are
frequently not motivated to continue a more active
and healthy life style after returning home, and
benefits usually dissolve over time. Ideally, when
the general practitioner and/or practice nurse
would be involved in the PR program, they could
partake in counteracting this imminent lack of mo-
tivation, and could support the patient in maintain-
ing physical exercise training on a daily basis. In
reality, primary physicians are rarely involved in
rehabilitative efforts, and as a result, largely unable
to support program methods or integrate the pro-
gram into their plans of continuous care [23]. What
is needed for a successful long term effective in-
tervention, accessible for all eligible patients in
primary care, is to integrate the tools of PR into
standard care, as was also suggested before by oth-
er authors [18, 23, 24], which will likely lead to
substantial cost reduction. Our case would gain
strength when it would no longer be doubted that
home-based or outreaching PR programs can in
fact be as efficacious as more traditional inpatient
programs, and would be considered an equivalent
alternative in less severe patients [7, 25].
Reactivation
In chronic disease conditions, patients not un-
commonly express feelings of helplessness, nega-
tively colored thoughts and a diminished belief in
a useful and worthwhile future. Anxiety and de-
pression appear frequently, and can even occur in
mildly affected patients [26]. Illness perceptions in
COPD patients have been proven to influence their
quality of life: increased attention to symptoms,
less positive beliefs about the effects and outcomes
of illness and strong emotional reactions to the ill-
ness have found to be associated with lower quali-
ty of life scores [27]. In the same way, patients
with a current depression, previous history of alco-
hol dependency and those who perceive that their
actions have a low influence over their disease
course may have difficulty with learning and ap-
plying self-management plans [28].
In COPD, there is a saddening lack of commu-
nication between healthcare providers and pa-
tients. As a striking example, up to 50% of COPD
exacerbations are not reported to healthcare
providers [29].This troublesome lack of communi-
cation could be the result of the negative spiral of
dyspnoea, deconditioning and social deprivation
that COPD patients find themselves in [30].
Through their daily decisions about taking
medication, applying self-measurements and per-
forming exercise, people with chronic diseases
play a central role in determining the course of
their disease [3, 32]. Because suboptimal adher-
ence is associated with a significant health and
economic burden in patients with COPD [33], ef-
forts must be aimed at changing an attitude of per-
ceived helplessness into an active approach, in or-
der to break through this negative spiral. In other
words, acquiring and applying self-management
skills for an individual patient should be a crucial
part of our treatment plan.
Ideally, patients and health care providers con-
stitute partners in disease management, in order to
take better control over daily symptoms and man-
agement. In these continuous decision-making
processes, a clearly formulated written action plan
in combination with approachable and committed
health care providers can be a helpful and reliable
instrument.
The concept of written action plans is based on
their successful application in asthma patients,
where programs that enable people to adjust their
medication dosage using a written action plan ap-
pear to be more effective than other forms of asth-
ma self-management [34]. In COPD, however,
pharmacological treatment is considerably less ef-
fective than in asthma patients.
Nevertheless, it has been demonstrated that ac-
tion plans can be helpful in guiding COPD patients
to recognize and react appropriately to an exacer-
bation, even in cases where limited COPD educa-
tion is provided [35]. In practice, patients must be
trained in adequate symptom recognition and en-
couraged to state individual goals for the coming
six months, which should then be put on record.
Information provided by general practitioners or
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practice nurses through different stages of disease
must be directed to these goals and can result in an
individualized treatment plan, designed realistical-
ly in collaboration with the patient. When written
and signed by the patient, patients will gain a
greater feeling of self-efficacy and increase in-
volvement to achieve these targets. For example,
when the personal goal is formulated as ‘to go bik-
ing for 30 minutes every other day’ or ‘play in the
park with my grandchildren during weekends,
without acute hindrance by feelings of breathless-
ness’, efforts must be made to maximize exercise
tolerance. If the target is ‘to quit smoking within
two weeks’, different smoking cessation therapies
and behavioral guidance strategies must be ex-
plored. When goals are chosen that are close to
one’s beliefs, needs and personal situation, the im-
pact will be greater.
General practitioners and nurse practitioners
have a unique position: they are often familiar with
the patients’ habitat, are easily involved in one’s
family situation and patients usually report a great
trust in their general practitioner. It is essential for
partners and relatives to be involved as they can
offer support in achieving desired prospects in fu-
ture. In keeping goals simple, realistic, relevant for
daily life and patient-driven, patients’ self-efficacy
will be supported and, as a result, intrinsic motiva-
tion will increase. In formulating these relevant
and realistic goals, modern techniques such as mo-
tivational interviewing can be very useful, but re-
quire additional training of practice nurses and/or
other health personnel [36].
Self-management is a ‘hot topic’ in current
COPD management, and an increasing number of
healthcare professionals agree that patients suffer-
ing of a chronic disease should receive support to
help them self-manage their disease as effectively
as possible [32]. A well informed patient will be
better enabled to make his or her own decisions
and can assist in maintaining healthy behaviours
during different stages and complications when
disease progresses [32]. Self-management educa-
tion has proven to be effective as it increases
knowledge and enhances self-confidence [37].
Furthermore, proper self-management is associat-
ed with a reduction in COPD-related hospital ad-
missions [38].
Integrated disease management programmes
in primary care
At present, the majority of COPD patients pre-
sent themselves in a primary care setting, of which
an estimated 80% are suffering from mild to mod-
erate disease (see table 1).
The World Health Organisation promotes pri-
mary care as the most viable cost-effective setting
to combat non-communicable diseases on a global
scale [39], anticipating a substantial need for
chronic disease-management in coming decades.
Due to the resulting large-scale shift of COPD pa-
tients from secondary and tertiary care to primary
care, general practitioners and practice nurses find
themselves at a focal point in the organisation of
care for COPD patients.
COPD remains a complex disease to treat.
Multidisciplinary collaboration can improve diag-
nosis and management of COPD in primary care
[40]. To establish a program of interventions based
on individual needs and strengths, sufficient coop-
eration within several disciplines in primary care
and collaboration with secondary and tertiary care
is necessary. As a result, a multidisciplinary team
should be formed, in which different health care
workers participate and contribute to the required
care in their field of expertise, e.g. physiothera-
pists, general practitioners, pulmonary physicians,
dieticians and practice nurses. Patients are at a cen-
tral position and their role in achieving success is
decisive. An integrated disease management
(IDM) program, where the elements of PR are in-
tegrated into a tailor-made program consisting of
self-management, regular exercise and individual-
ized targets, can effectively introduce certain ele-
ments of pulmonary rehabilitation into the large
population that can be reached by primary care
(see figure 1). Patients are managed in their own
home-setting, making the benefits accessible for
all COPD patients eligible.
Table 1. - Current and expected rise in prevalence according to GOLD stage in the Dutch COPD population
Gold stage Characteristics Current prevalence and expected rise in coming decade
FEV1/FVC < 0.7I Mild FEV1 > 80%
28% → + 120%
FEV1/FVC < 0.7II Moderate 50% ≤ FEV1 < 80%
54% → + 27%
FEV1/FVC < 0.7III Severe 30% ≤ FEV1 < 50%
15% → + 30%
FEV1/FVC < 0.7IV Very severe FEV1 < 30%
3% → + 120%
FEV1: Forced Expiratory Volume in 1 second; FVC: Forced Vital Capacity.
Modified from: Smeele IJ, van Weel C, van Schayck CP, van der Molen T, Thoonen B, Schermer T, et al. Dutch College of
General Practitioners Guideline for COPD Diagnosis. Huisarts Wet 2007; 50 (8): 362-79.
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counselling in a community-based, multi-
disciplinary setting. Quality of life, func-
tional exercise capacity, and breathless-
ness remained significantly favourable in
the intervention group versus usual care
over the entire two-year intervention [42].
Despite encouraging results in earli-
er studies as described above, more re-
search is needed. We recommend large
pragmatic randomized controlled trials,
addressing the costs and long-term clin-
ical effectiveness of an IDM program in
primary care.
Conclusion
PR has proven to be the most effec-
tive treatment for COPD patients [4, 5,
11, 12], but its use in daily practice is
limited due to low availability and ac-
cessibility, high costs and short duration
of administration [13-17]. When a pro-
gram is provided where the elements of
PR are integrated into a tailor-made pro-
gram consisting of proper self-management, regu-
lar exercise and based on individualized targets,
people can be managed in their home environ-
ment, while primary care providers are more in-
volved and in the position to coach this process di-
rectly [41]. Training in motivational interviewing
techniques is a prerequisite to actively include per-
sonal goals and stimulate the patients’ intrinsic
motivation. Our aim should be to make the bene-
fits of PR available to the large population of eli-
gible COPD patients, and possibly diminish dis-
ease progression in less severe patients at an earli-
er stage. Encouraging results have been published
[30, 41, 43], but more research is needed in the
form of a proper cost-effectiveness analysis.
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